Algorithme Pharma, a leading early stage clinical research organization, is pleased to announce the expansion of its clinical facility located in Montreal, Quebec, with the addition of a 7th clinical unit for a total 265 beds.
Algorithme Pharma, a leading early stage clinical research organization, is pleased to offer sponsors increased patient access in key therapeutic areas through the strategic partnership with Hôpital Maisonneuve-Rosemont (HMR).
Algorithme Pharma is pleased to announce the signing of a strategic alliance with the University of Montreal Hospital Research Centre (CRCHUM), allowing for access to an extensive pool of patients and the new 520,000 sq. ft. research complex (CRCHUM) for conducting complex early stage clinical trials.
(Laval, Québec, Canada May 14, 2013) – The Altasciences Group is proud to announce the addition of Vince and Associates Clinical Research to its team providing comprehensive Phase I/IIa clinical drug development capabilities.
Collaborative results recently presented at the 14th Annual Immunogenicity for Biotherapeutics Conference in Baltimore 18-20 March
TORONTO - SQI Diagnostics Inc. (TSX-V: SQD), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics (“SQI”), and Algorithme Pharma (“Algorithme”) today announced that they have completed the multiplexed proof of concept assay targeted at immunogenicity testing of heparin and heparin-based low molecular weight (LMWT) biosimilar compounds using SQI’s Ig_PLEX™ multiplexing technology.